RxDoctor Payments Data

Jincy Mathew, PA

Physician Assistant · Detroit, MINPI 1093953648

Payments from drug & device makers

$4,958in general payments, 2019–2025

Across 153 payments — averaging $32.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$859
  • Novartis$734
  • AbbVie$486
  • Johnson & Johnson$433
  • Galderma Laboratories, L.p.$353
  • Pfizer$302
  • plus $2K from 19 others
$280in research payments, 2019–2025

Across 1 payment — averaging $280.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$280

What the payments were for

  • Food & beverage$4,958100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,958 in reported general payments places this provider in the 90th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$40,647
Medicare patients
209
Services billed
694

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate199$8,622
Mometasone Furoate315$8,008
Triamcinolone Acetonide352$6,931
Ketoconazole348$6,114
Clindamycin Phosphate165$3,895
Halobetasol Propionate40$2,531
Ammonium Lactate89$1,326
Hydroxychloroquine Sulfate18$1,326
Metronidazole35$1,191
Desonide15$1,174
Imiquimod30$1,025
Hydrocortisone139$963
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc16$915
Fluocinonide22$858
Betamethasone Dipropionate22$807

Paid to pharmacies, not to this prescriber.

Other physician assistant in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →